Aptuit LLC, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in the United States. Founded in 2004, the company has established itself as a leader in drug development and laboratory services, catering to clients across North America and Europe. Aptuit offers a comprehensive range of services, including preclinical and clinical development, formulation, and analytical testing, distinguished by its commitment to scientific excellence and innovation. The company’s unique approach integrates advanced technologies and a deep understanding of regulatory requirements, ensuring efficient pathways to market for its clients' products. With a strong market position, Aptuit has achieved notable milestones, including strategic partnerships and successful project completions that underscore its reputation for reliability and expertise in the industry.
How does Aptuit LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Aptuit LLC's score of 91 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aptuit LLC, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Evotec SE, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, Aptuit LLC inherits emissions data and reduction initiatives from Evotec SE, which is committed to addressing climate change through various sustainability efforts. While no specific reduction targets or achievements are listed for Aptuit LLC, the overarching initiatives from Evotec SE include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to establish science-based emissions reduction targets and enhance transparency in climate-related disclosures. Aptuit LLC's climate commitments are aligned with industry standards, focusing on reducing carbon footprints and promoting sustainability. However, without specific emissions data or reduction targets, the company's current impact on climate change remains unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 28,000 | 00,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 32,701,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | 1,464,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Aptuit LLC's Scope 3 emissions, which decreased by 34% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 70% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aptuit LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.